Product Pathways - Neuroscience
Ataxin-1 Antibody #2177
|2177S||100 µl (10 western blots)||---||In Stock||---|
|2177||carrier free and custom formulation / quantity||email request|
|W||1:1000||Human, Mouse, Rat, D. melanogaster||Endogenous||105||Rabbit|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting
Specificity / Sensitivity
Ataxin-1 Antibody detects endogenous levels of total ataxin-1 protein.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to human ataxin-1. Antibodies are purified by protein A and peptide affinity chromatography.
Spinocerebellar ataxia 1 (SCA1), an autosomal dominant neurodegenerative disorder, is characterized by slurred speech, loss of limb coordination, and gait abnormalities resulting from the degeneration of cerebellar Purkinje cells and of a subset of brainstem neurons (1). Individuals with SCA1 have a highly polymorphic CAG repeat expansion encoding a polyglutamine tract in ataxin-1 (2). Akt phosphorylates ataxin-1 at Ser776, which regulates an association with 14-3-3. This interaction increases ataxin-1 stabilization and accumulation resulting in enhanced neurodegeneration (3). In addition, HSP70 controls the effect that phosphorylation has on ataxin-1 stability (4).
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
- 9636 14-3-3 β/α Antibody
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7727 Biotinylated Protein Ladder Detection Pack
- 4876 HSP70 (D69) Antibody
- 2773 Huntingtin Antibody
- 9601 Phospho-(Ser) 14-3-3 Binding Motif Antibody
- 9916 Phospho-Akt Pathway Antibody Sampler Kit
- 6883 SignalFire™ ECL Reagent
- 12757 SignalFire™ Elite ECL Reagent
- 12630 SignalFire™ Plus ECL Reagent
This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.